CD3⁺ cells within involved skin lesions decrease during lesion regression while receiving rhIL-12. (A) Biopsy specimen of involved skin from patient 6 at baseline. (B) Biopsy specimen of same lesion as in (A) when lesion was nearly completely resolved during rIL-12 treatment.